Bernd Schlereth

Safety and immunogenicity of IMVAMUNE, a promising candidate as a third generation smallpox vaccine

Jens Vollmar, Nathaly Arndtz, Karl M. Eckl et al. · Vaccine · 2005 · 170 citations

Vaccination, Vaccine Safety, Vaccine Development +8

Successful Vaccine-Induced Seroconversion by Single-Dose Immunization in the Presence of Measles Virus-Specific Maternal Antibodies

Bernd Schlereth, John K. Rose, Linda Buonocore et al. · Journal of Virology · 2000 · 104 citations · Full text

Discovery and characterization of COVA322, a clinical-stage bispecific TNF/IL-17A inhibitor for the treatment of inflammatory diseases

Michela Silacci, Wibke Lembke, Richard Woods et al. · mAbs · 2015 · 90 citations · Full text

Immune Regulation, Immunology, Pathology +19

Successful mucosal immunization of cotton rats in the presence of measles virus-specific antibodies depends on degree of attenuation of vaccine vector and virus dose

Bernd Schlereth, Linda Buonocore, Annette Tietz et al. · Journal of General Virology · 2003 · 48 citations

Vaccination, Mucosal Vaccination, Veterinary Vaccine +13

Vaccination with recombinant modified vaccinia virus Ankara protects against measles virus infection in the mouse and cotton rat model

Gerald Weidinger, Marion Ohlmann, Bernd Schlereth et al. · Vaccine · 2001 · 34 citations

Vaccinology, Vaccination, Mucosal Vaccination +9